Basic Info
  • Grade: Pharmaceutical Grade

    Factory Location: Shandong

    Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

  • Sample Provided: no

    Prasugrel with CAS 150322-43-3 is a platelet inhibitor for acute coronary syndromes planned for percutaneous coronary intervention.

    Prasugrel (CAS 150322-43-3), Prasugrel is a prodrug and is rapidly metabolized to a pharmacologically active metabolite and inactive metabolites. The active metabolite has an elimination half-life of about 7 hr (range 2–15 hr). Healthy subjects, patients with stable atherosclerosis, and patients undergoing PCI show similar pharmacokinetics.

    The product above are not for sales where the patents are applicable and still valid.

Send your message to this supplier
  • From:
  • To:
    Viwit Pharmaceutical Co., LTD
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service